Emil Kumar

430 total citations
11 papers, 204 citations indexed

About

Emil Kumar is a scholar working on Pathology and Forensic Medicine, Oncology and Cancer Research. According to data from OpenAlex, Emil Kumar has authored 11 papers receiving a total of 204 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 8 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Emil Kumar's work include Lymphoma Diagnosis and Treatment (8 papers), Viral-associated cancers and disorders (4 papers) and CAR-T cell therapy research (3 papers). Emil Kumar is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Viral-associated cancers and disorders (4 papers) and CAR-T cell therapy research (3 papers). Emil Kumar collaborates with scholars based in United Kingdom, United States and Australia. Emil Kumar's co-authors include Koorosh Korfi, Findlay Bewicke‐Copley, Giuseppe Palladino, Jun Wang, Jessica Okosun, Jude Fitzgibbon, Kirsty Thomson, James Day, Jonathan Lambert and Marie Scully and has published in prestigious journals such as Blood, AIDS and British Journal of Haematology.

In The Last Decade

Emil Kumar

10 papers receiving 204 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emil Kumar United Kingdom	6	84	58	52	50	47	11	204
Kota Yoshifuji Japan	6	53 0.6×	45 0.8×	111 2.1×	23 0.5×	34 0.7×	28	208
Douglas Filipenko Canada	9	111 1.3×	24 0.4×	74 1.4×	42 0.8×	22 0.5×	17	314
Xiaowen Qian China	12	91 1.1×	18 0.3×	87 1.7×	42 0.8×	32 0.7×	42	324
Hira Shaikh United States	8	101 1.2×	30 0.5×	58 1.1×	34 0.7×	11 0.2×	48	218
Manon Queudeville Germany	10	135 1.6×	42 0.7×	97 1.9×	19 0.4×	22 0.5×	27	332
Gehong Dong China	8	91 1.1×	77 1.3×	64 1.2×	104 2.1×	65 1.4×	25	290
Anne Lok France	10	130 1.5×	43 0.7×	76 1.5×	62 1.2×	8 0.2×	21	243
Ching‐Hon Pui United States	7	68 0.8×	15 0.3×	87 1.7×	47 0.9×	44 0.9×	11	288
Rebeca Rodríguez‐Veiga Spain	10	117 1.4×	38 0.7×	147 2.8×	15 0.3×	21 0.4×	39	326
Muriel Picard France	10	67 0.8×	48 0.8×	55 1.1×	15 0.3×	13 0.3×	25	260

Countries citing papers authored by Emil Kumar

Since Specialization

Citations

This map shows the geographic impact of Emil Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emil Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emil Kumar more than expected).

Fields of papers citing papers by Emil Kumar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emil Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emil Kumar. The network helps show where Emil Kumar may publish in the future.

Co-authorship network of co-authors of Emil Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Emil Kumar. A scholar is included among the top collaborators of Emil Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emil Kumar. Emil Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Sanderson, Robin, Jane E. Norman, Joht Singh Chandan, et al.. (2025). CAR T access and outcomes in large B‐cell lymphoma according to ethnicity and socioeconomic deprivation in the UK. British Journal of Haematology. 206(4). 1178–1185. 1 indexed citations

Kumar, Emil & Jessica Okosun. (2025). Follicular Lymphoma: Current Therapeutic Landscape and Future Prospects. Hematological Oncology. 43(S2). e70070–e70070.

Kumar, Emil, Koorosh Korfi, Findlay Bewicke‐Copley, et al.. (2024). CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphoma. British Journal of Haematology. 205(5). 1804–1809. 1 indexed citations

Kumar, Emil, Giuseppe Palladino, Janet Matthews, et al.. (2022). Longitudinal Single Cell Analyses Reveal the Co-Evolutionary Dynamics of the Tumor and Microenvironment Accompanying Follicular Lymphoma Transformation. Blood. 140(Supplement 1). 748–749. 1 indexed citations

Kumar, Emil, et al.. (2021). Pathogenesis of follicular lymphoma: genetics to the microenvironment to clinical translation. British Journal of Haematology. 194(5). 810–821. 25 indexed citations

Fox, Thomas A., Amy A. Kirkwood, James Day, et al.. (2020). Clinical outcomes and risk factors for severe COVID‐19 in patients with haematological disorders receiving chemo‐ or immunotherapy. British Journal of Haematology. 191(2). 194–206. 49 indexed citations

Kumar, Emil, Jessica Okosun, & Jude Fitzgibbon. (2020). The Biological Basis of Histologic Transformation. Hematology/Oncology Clinics of North America. 34(4). 771–784. 8 indexed citations

Bewicke‐Copley, Findlay, Emil Kumar, Giuseppe Palladino, Koorosh Korfi, & Jun Wang. (2019). Applications and analysis of targeted genomic sequencing in cancer studies. Computational and Structural Biotechnology Journal. 17. 1348–1359. 92 indexed citations

Kumar, Emil & Jessica Okosun. (2019). Follicular lymphoma genomics. HemaSphere. 3(S2). 79–81. 1 indexed citations

10.

Heward, James A., Emil Kumar, Koorosh Korfi, Jessica Okosun, & Jude Fitzgibbon. (2018). Precision medicine and lymphoma. Current Opinion in Hematology. 25(4). 329–334. 6 indexed citations

11.

Hamzah, Lisa, John Booth, Sophie José, et al.. (2015). Renal tubular disease in the era of combination antiretroviral therapy. AIDS. 29(14). 1831–1836. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact